TB Alliance regimen development for multidrug-resistant tuberculosis. [electronic resource]
Producer: 20180215Description: 38-41 p. digitalISSN:- 1815-7920
- Antitubercular Agents -- therapeutic use
- Clinical Protocols
- Diarylquinolines -- therapeutic use
- Dose-Response Relationship, Drug
- Ethambutol -- therapeutic use
- Extensively Drug-Resistant Tuberculosis -- drug therapy
- Fluoroquinolones -- therapeutic use
- Humans
- Isoniazid -- therapeutic use
- Linezolid -- therapeutic use
- Moxifloxacin
- Nitroimidazoles -- therapeutic use
- Pyrazinamide -- therapeutic use
- Randomized Controlled Trials as Topic
- Research Design
- Rifampin -- therapeutic use
- Tuberculosis, Multidrug-Resistant -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.